Gettys T W, Sheriff-Carter K, Moomaw J, Taylor I L, Raymond J R
Department of Medicine, Medical University of South Carolina, Charleston 29425.
Anal Biochem. 1994 Jul;220(1):82-91. doi: 10.1006/abio.1994.1302.
G proteins are heterotrimeric membrane-associated proteins that couple a large number of receptors to a variety of effector systems within the cell. Characterization of G proteins expressed in a particular cell type represents an important first step in defining the potential candidates to which a receptor might couple. A difficulty often encountered using G protein antisera from various commercial and private sources is relating the intensity of bands on a Western blot to the relative amount of G protein present in a membrane preparation. This problem is especially noteworthy when comparing across G protein subtypes due to differences in titer, affinity, and specificity among various antisera. Conventional approaches to obtaining G protein standards of sufficient purity to address these issues in a quantitative manner are time-consuming and difficult, but the procedures outlined herein demonstrate a method for using DEAE fractions from Escherichia coli expressing individual alpha-subunits. The key features of the present approach are to estimate saturable GTP gamma S binding in each alpha-subunit preparation and calculate the moles of alpha-subunit present in the respective preparations based on the known stoichiometry of GTP gamma S binding (1:1). The extent of correspondence between GTP gamma S binding and immunoreactivity is then determined by trypsin protection assays, which estimate the proportion of immunodetectable G protein which can bind GTP gamma S. After characterization in this manner, DEAE fractions from bacteria transformed with the respective cDNA for Gi alpha-1, G1 alpha-2, and G1 alpha-3 were used to construct standard curves on Western blots and estimate endogenous G protein concentrations in cell lines (CHO and HeLa) and across species (rat and mouse) in isolated adipocyte preparations. Plasma membranes from CHO cells contained Gi alpha-2 (4.8 +/- 0.3 pmol/mg protein) and Gi alpha-3 (0.6 +/- 0.1 pmol/mg protein), but not Gi alpha-1, while HeLa cell membranes contained Gi alpha-1 (0.11 +/- 0.01 pmol/mg protein) and Gi alpha-3 (1.3 +/- 0.1 pmol/mg protein), but not Gi alpha-2. In contrast, rat and mouse adipocyte membranes contained Gi alpha-1 (48 +/- 2 vs 36 +/- 2 pmol/mg protein), Gi alpha-2 (77 +/- 1.5 vs 25 +/- 1.4 pmol/mg protein), and Gi alpha-3 (26 +/- 1.2 vs 15 +/- 1 pmol/mg protein). The method described herein provides an innovative solution to the technically difficult problem of obtaining pure standards for the assay of G protein alpha-subunits and does so using simple biochemical and immunological techniques.
G蛋白是异源三聚体膜相关蛋白,它将大量受体与细胞内多种效应器系统偶联起来。鉴定特定细胞类型中表达的G蛋白是确定受体可能偶联的潜在候选物的重要第一步。使用来自各种商业和私人来源的G蛋白抗血清时,经常遇到的一个困难是将蛋白质免疫印迹上条带的强度与膜制剂中存在的G蛋白相对量联系起来。当比较不同G蛋白亚型时,由于各种抗血清在效价、亲和力和特异性方面存在差异,这个问题尤其值得注意。以定量方式获得足够纯度的G蛋白标准品以解决这些问题的传统方法既耗时又困难,但本文概述的程序展示了一种使用来自表达单个α亚基的大肠杆菌的DEAE级分的方法。本方法的关键特征是估计每个α亚基制剂中可饱和的GTPγS结合,并根据已知的GTPγS结合化学计量比(1:1)计算相应制剂中存在的α亚基摩尔数。然后通过胰蛋白酶保护试验确定GTPγS结合与免疫反应性之间的对应程度,该试验估计可免疫检测的能结合GTPγS的G蛋白比例。以这种方式进行表征后,用分别针对Giα-1、G1α-2和G1α-3的cDNA转化的细菌的DEAE级分在蛋白质免疫印迹上构建标准曲线,并估计细胞系(CHO和HeLa)以及分离的脂肪细胞制剂中跨物种(大鼠和小鼠)的内源性G蛋白浓度。CHO细胞膜含有Giα-2(4.8±0.3 pmol/mg蛋白质)和Giα-3(0.6±0.1 pmol/mg蛋白质),但不含有Giα-1,而HeLa细胞膜含有Giα-1(0.11±0.01 pmol/mg蛋白质)和Giα-3(1.3±0.1 pmol/mg蛋白质),但不含有Giα-2。相比之下,大鼠和小鼠脂肪细胞膜含有Giα-1(48±2对36±2 pmol/mg蛋白质)、Giα-2(77±1.5对25±1.4 pmol/mg蛋白质)和Giα-3(26±1.2对15±1 pmol/mg蛋白质)。本文所述方法为获得用于G蛋白α亚基测定的纯标准品这一技术难题提供了一种创新解决方案,并且是使用简单的生化和免疫技术做到这一点的。